EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieOpen Access

Amyloid PET in Sporadic Early‐ Versus Late‐Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts

Julien Lagarde iD, Piyush Maiti, Daniel R Schonhaut, Ganna Blazhenets iD, Jiaxiuxiu Zhang, Ani Eloyan, Maryanne Thangarajah, Alexander Taurone, Isabel Elaine Allen, David N Soleimani-Meigooni iD, Ehud Zeltzer iD, Charles Windon iD und 44 weitere

Annals of Neurology · 2025-08 · 98 (2) · 236-248

DOI: 10.1002/ana.27233 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annals of Neurology, online erschienen am 17.03.2025. Verfasst von Julien Lagarde und 55 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California, San Francisco, San Francisco, CA. Hauptthemen laut MEDLINE: Alzheimer Disease, Positron-Emission Tomography, Brain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Alzheimer's Association, National Institute of Health / National Institute on Aging, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Early‐onset Alzheimer's disease (EOAD) and late‐onset Alzheimer's disease (LOAD) differ in many respects. Here, we address the issue of possible differences in fibrillar amyloid pathology as measured by positron emission tomography (PET), which remains unresolved due to the lack of large‐scale comparative studies.

Methods

Three hundred ninety‐nine cognitively impaired participants younger than 65 years of age from the multicenter Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) and 450 cognitively impaired participants older than 65 years from the Alzheimer's Disease Neuroimaging Initiative (ADNI) underwent clinical assessment, brain magnetic resonance imaging (MRI), and amyloid PET and were included in this study. We compared amyloid PET outcomes (positivity rate based on visual read and quantified tracer uptake expressed as Centiloids [CLs]) between the 2 cohorts and studied their association with age, sex, APOE genotype, and cognition.

Results

The amyloid positivity rate was higher in LEADS (78%, 95% confidence interval [CI] = 74–82) than in ADNI (71%, 95% CI = 67–75, p = 0.02). Lower Mini‐Mental State Examination (MMSE) and APOE4 genotype increased the odds of amyloid positivity in both cohorts. Visually positive scans had higher CLs in LEADS (EOAD, mean = 95.3 ± 26.1) than in ADNI (LOAD, mean = 80.9 ± 36.8, p < 0.0001), predominantly in parietal cortex/precuneus, superior temporal, and frontal cortices. In amyloid‐positive patients, (1) CLs were higher in female patients in both cohorts; (2) APOE4 carriership was associated with lower CLs in EOAD, which was not observed in LOAD; and (3) correlations between CLs and MMSE scores were significantly stronger in EOAD than in LOAD.

Interpretation

Differences in the burden of amyloid pathology may contribute to differences in clinical and anatomic patterns in sporadic EOAD and LOAD, and have implications for optimizing therapeutic strategies in each group. ANN NEUROL 2025;98:236–248

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePositron-Emission TomographyBrainHumansFemaleMaleAgedMiddle AgedCohort StudiesAge of OnsetMagnetic Resonance ImagingLongitudinal StudiesAged, 80 and overAmyloid beta-PeptidesCognitive DysfunctionAmyloid

Substanzen

Amyloid beta-PeptidesAmyloid

Autor:innen und Institutionen

  • Department of Neurology, University of California, San Francisco, San Francisco, CA.
  • Department of Biostatistics, Center for Statistical Sciences, Brown University, Providence, RI.
  • Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.
  • Global Brain Health Institute, The university of California, San Francisco, California, CA.
  • Department of Neurology, Indiana University School of Medicine, Indianapolis, IN.
  • Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.

ORCID-Profile: Julien Lagarde, Ganna Blazhenets, David N Soleimani-Meigooni, Ehud Zeltzer, Charles Windon, Maison Abu Raya, Agathe Vrillon, Kelly N Nudelman, Prashanthi Vemuri, Gregory S Day, Joseph C Masdeu, Erik Musiek, Sharon Sha, Thomas S Wingo, Renaud La Joie

Förderung

  • Alzheimer's Association
  • National Institute of Health / National Institute on Aging
  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Lagarde, J., Maiti, P., Schonhaut, D. R., Blazhenets, G., Zhang, J., Eloyan, A., Thangarajah, M., Taurone, A., Allen, I. E., Soleimani-Meigooni, D. N., Zeltzer, E., Windon, C., Abu Raya, M., Vrillon, A., Smith, K., Shankar, R., Amuiri, A., Rocha, S., Hammers, D. B., …, & LEADS Consortium for the Alzheimer's Disease Neuroimaging Initiative (2025). Amyloid PET in Sporadic Early‐ Versus Late‐Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts. Annals of Neurology, 98(2), 236-248. https://doi.org/10.1002/ana.27233

Vancouver

Lagarde J, Maiti P, Schonhaut DR, Blazhenets G, Zhang J, Eloyan A, et al. Amyloid PET in Sporadic Early‐ Versus Late‐Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts. Annals of Neurology. 2025;98(2):236-248. doi:10.1002/ana.27233

BibTeX
@article{Lagarde2025,
  author = {Lagarde, Julien and Maiti, Piyush and Schonhaut, Daniel R and Blazhenets, Ganna and Zhang, Jiaxiuxiu and Eloyan, Ani and Thangarajah, Maryanne and Taurone, Alexander and Allen, Isabel Elaine and Soleimani-Meigooni, David N and Zeltzer, Ehud and Windon, Charles and Abu Raya, Maison and Vrillon, Agathe and Smith, Karen and Shankar, Ranjani and Amuiri, Alinda and Rocha, Salma and Hammers, Dustin B and Dage, Jeffrey L and Nudelman, Kelly N and Kirby, Kala and Aisen, Paul and Koeppe, Robert and Landau, Susan M and Carrillo, Maria C and Touroutoglou, Alexandra and Brickhouse, Michael and Vemuri, Prashanthi and Beckett, Laurel and Raman, Rema and Atri, Alireza and Day, Gregory S and Duara, Ranjan and Graff-Radford, Neill R and Honig, Lawrence S and Jones, David T and Masdeu, Joseph C and Mendez, Mario F and Womack, Kyle and Musiek, Erik and Onyike, Chiadi U and Riddle, Meghan and Grant, Ian M and Rogalski, Emily and Johnson, Erik C B and Salloway, Stephen and Sha, Sharon and Turner, R Scott and Wingo, Thomas S and Wolk, David A and Dickerson, Bradford C and Apostolova, Liana G and La Joie, Renaud and Rabinovici, Gil D and LEADS Consortium for the Alzheimer's Disease Neuroimaging Initiative, LEADS Consortium for the Alzheimer's Disease Neuroimaging Initiative},
  title = {Amyloid PET in Sporadic Early‐ Versus Late‐Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts},
  journal = {Annals of Neurology},
  year = {2025},
  volume = {98},
  number = {2},
  pages = {236--248},
  doi = {10.1002/ana.27233}
}
Kostenlos starten →